A citation-based method for searching scientific literature

Robert Ta, Chris Santini, Patricia Gou, Greg Lee, Yu Chuan Tai, Cathal O'Brien, Marcel Fontecha, Cliona Grant, Larry Bacon, Stephen Finn, Elisabeth Vandenberghe, Fiona Quinn, Rajiv Dua, Richard Flavin. J Mol Diagn 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy.
Chulin Sha, Sharon Barrans, Francesco Cucco, Michael A Bentley, Matthew A Care, Thomas Cummin, Hannah Kennedy, Joe S Thompson, Rahman Uddin, Lisa Worrillow,[...]. J Clin Oncol 2019
106
100

Stromal cell contribution to human follicular lymphoma pathogenesis.
Frédéric Mourcin, Céline Pangault, Rada Amin-Ali, Patricia Amé-Thomas, Karin Tarte. Front Immunol 2012
41
100

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning.
Margaret A Shipp, Ken N Ross, Pablo Tamayo, Andrew P Weng, Jeffery L Kutok, Ricardo C T Aguiar, Michelle Gaasenbeek, Michael Angelo, Michael Reich, Geraldine S Pinkus,[...]. Nat Med 2002
100


Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma.
Wyndham H Wilson, Ryan M Young, Roland Schmitz, Yandan Yang, Stefania Pittaluga, George Wright, Chih-Jian Lih, P Mickey Williams, Arthur L Shaffer, John Gerecitano,[...]. Nat Med 2015
713
100

Template for Reporting Results of Biomarker Testing of Specimens From Patients With Diffuse Large B-Cell Lymphoma, Not Otherwise Specified.
Eric Duncavage, Ranjana H Advani, Steven Agosti, Philip Foulis, Christine Gibson, Loveleen Kang, Joseph D Khoury, L Jeffrey Medeiros, Robert S Ohgami, Dennis P O'Malley,[...]. Arch Pathol Lab Med 2016
3
100

Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma.
J J F Muris, C J L M Meijer, W Vos, J H J M van Krieken, N M Jiwa, G J Ossenkoppele, J J Oudejans. J Pathol 2006
177
100

Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL.
Wyndham H Wilson, George W Wright, Da Wei Huang, Brendan Hodkinson, Sriram Balasubramanian, Yue Fan, Jessica Vermeulen, Martin Shreeve, Louis M Staudt. Cancer Cell 2021
39
100

Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
Tina Marie Green, Ken H Young, Carlo Visco, Zijun Y Xu-Monette, Attilio Orazi, Ronald S Go, Ole Nielsen, Ole V Gadeberg, Torben Mourits-Andersen, Mikael Frederiksen,[...]. J Clin Oncol 2012
482
100

B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in mice.
Gero Knittel, Paul Liedgens, Darya Korovkina, Jens M Seeger, Yussor Al-Baldawi, Mona Al-Maarri, Christian Fritz, Katerina Vlantis, Svetlana Bezhanova, Andreas H Scheel,[...]. Blood 2016
76
100

The stromal cell marker SPARC predicts for survival in patients with diffuse large B-cell lymphoma treated with rituximab.
Paul N Meyer, Kai Fu, Timothy Greiner, Lynette Smith, Jan Delabie, Randy Gascoyne, German Ott, Andreas Rosenwald, Rita Braziel, Elias Campo,[...]. Am J Clin Pathol 2011
54
100

Clinical and Biological Subtypes of B-cell Lymphoma Revealed by Microenvironmental Signatures.
Nikita Kotlov, Alexander Bagaev, Maria V Revuelta, Jude M Phillip, Maria Teresa Cacciapuoti, Zoya Antysheva, Viktor Svekolkin, Ekaterina Tikhonova, Natalia Miheecheva, Natalia Kuzkina,[...]. Cancer Discov 2021
49
100

The Effect of the Tumor Microenvironment on Lymphoid Neoplasms Derived from B Cells.
Giuseppe Ingravallo, Roberto Tamma, Giuseppina Opinto, Tiziana Annese, Francesco Gaudio, Giorgina Specchia, Tommasina Perrone, Pellegrino Musto, Gerardo Cazzato, Emilio Bellitti,[...]. Diagnostics (Basel) 2022
1
100

CD4(+) tumor infiltrating lymphocytes are prognostic and independent of R-IPI in patients with DLBCL receiving R-CHOP chemo-immunotherapy.
Colm Keane, Devinder Gill, Frank Vari, Donna Cross, Lynn Griffiths, Maher Gandhi. Am J Hematol 2013
60
100

Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting.
Hirokazu Matsushita, Matthew D Vesely, Daniel C Koboldt, Charles G Rickert, Ravindra Uppaluri, Vincent J Magrini, Cora D Arthur, J Michael White, Yee-Shiuan Chen, Lauren K Shea,[...]. Nature 2012
807
100

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.
Andreas Rosenwald, George Wright, Wing C Chan, Joseph M Connors, Elias Campo, Richard I Fisher, Randy D Gascoyne, H Konrad Muller-Hermelink, Erlend B Smeland, Jena M Giltnane,[...]. N Engl J Med 2002
100

The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes.
A Alizadeh, M Eisen, R E Davis, C Ma, H Sabet, T Tran, J I Powell, L Yang, G E Marti, D T Moore,[...]. Cold Spring Harb Symp Quant Biol 1999
189
100

Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.
Anupama Reddy, Jenny Zhang, Nicholas S Davis, Andrea B Moffitt, Cassandra L Love, Alexander Waldrop, Sirpa Leppa, Annika Pasanen, Leo Meriranta, Marja-Liisa Karjalainen-Lindsberg,[...]. Cell 2017
561
100

A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications.
George W Wright, Da Wei Huang, James D Phelan, Zana A Coulibaly, Sandrine Roulland, Ryan M Young, James Q Wang, Roland Schmitz, Ryan D Morin, Jeffrey Tang,[...]. Cancer Cell 2020
270
100

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.
Bjoern Chapuy, Chip Stewart, Andrew J Dunford, Jaegil Kim, Atanas Kamburov, Robert A Redd, Mike S Lawrence, Margaretha G M Roemer, Amy J Li, Marita Ziepert,[...]. Nat Med 2018
754
100

Comparison of immunohistochemistry and gene expression profiling subtyping for diffuse large B-cell lymphoma in the phase III clinical trial of R-CHOP ± ibrutinib.
Sriram Balasubramanian, Songbai Wang, Christopher Major, Brendan Hodkinson, Michael Schaffer, Laurie H Sehn, Peter Johnson, Pier Luigi Zinzani, Jodi Carey, S Martin Shreeve,[...]. Br J Haematol 2021
3
100

Targeting the Tumor Microenvironment of Leukemia and Lymphoma.
Uta E Höpken, Armin Rehm. Trends Cancer 2019
38
100

Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue.
S Ciavarella, M C Vegliante, M Fabbri, S De Summa, F Melle, G Motta, V De Iuliis, G Opinto, A Enjuanes, S Rega,[...]. Ann Oncol 2018
64
100

Toward a New Molecular Taxonomy of Diffuse Large B-cell Lymphoma.
Daisuke Ennishi, Eric D Hsi, Christian Steidl, David W Scott. Cancer Discov 2020
19
100

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.
T R Golub, D K Slonim, P Tamayo, C Huard, M Gaasenbeek, J P Mesirov, H Coller, M L Loh, J R Downing, M A Caligiuri,[...]. Science 1999
100

Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma.
Anas Younes, Laurie H Sehn, Peter Johnson, Pier Luigi Zinzani, Xiaonan Hong, Jun Zhu, Caterina Patti, David Belada, Olga Samoilova, Cheolwon Suh,[...]. J Clin Oncol 2019
226
100

Outcomes of patients with relapsed/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapy.
Daniel J Landsburg, Mitchell E Hughes, Alexa Koike, David Bond, Kami J Maddocks, Ling Guo, Allison M Winter, Brian T Hill, Sarah L Ondrejka, Eric D Hsi,[...]. Blood Adv 2019
10
100

Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
Nathalie A Johnson, Graham W Slack, Kerry J Savage, Joseph M Connors, Susana Ben-Neriah, Sanja Rogic, David W Scott, King L Tan, Christian Steidl, Laurie H Sehn,[...]. J Clin Oncol 2012
661
100

Predictive and Prognostic Molecular Factors in Diffuse Large B-Cell Lymphomas.
Stefano A Pileri, Claudio Tripodo, Federica Melle, Giovanna Motta, Valentina Tabanelli, Stefano Fiori, Maria Carmela Vegliante, Saveria Mazzara, Sabino Ciavarella, Enrico Derenzini. Cells 2021
4
100

Tumor Microenvironment in Diffuse Large B-Cell Lymphoma: Role and Prognosis.
Alexandra Ioana Cioroianu, Patricia Irina Stinga, Liana Sticlaru, Mirela Daniela Cioplea, Luciana Nichita, Cristiana Popp, Florica Staniceanu. Anal Cell Pathol (Amst) 2019
30
100

Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group.
Annette M Staiger, Marita Ziepert, Heike Horn, David W Scott, Thomas F E Barth, Heinz-Wolfram Bernd, Alfred C Feller, Wolfram Klapper, Monika Szczepanowski, Michael Hummel,[...]. J Clin Oncol 2017
139
100

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy.
William W L Choi, Dennis D Weisenburger, Timothy C Greiner, Miguel A Piris, Alison H Banham, Jan Delabie, Rita M Braziel, Huimin Geng, Javeed Iqbal, Georg Lenz,[...]. Clin Cancer Res 2009
470
100


Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
100

Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma.
Julia González-Rincón, Miriam Méndez, Sagrario Gómez, Juan F García, Paloma Martín, Carmen Bellas, Lucía Pedrosa, Socorro M Rodríguez-Pinilla, Francisca I Camacho, Cristina Quero,[...]. PLoS One 2019
18
100

Prognostic Role of Tumor Microenvironment in DLBCL and Relation to Patients' Clinical Outcome: A Clinical and Immunohistochemical Study.
Doaa Shams-Deen Ghorab, Ahmed Mohamed Helaly, Hoda Saleh El Mahdi, Moawiah Khatatbeh, Afaf Taha Ibrahiem. Anal Cell Pathol (Amst) 2022
1
100

Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.
Alexandar Tzankov, Zijun Y Xu-Monette, Marc Gerhard, Carlo Visco, Stephan Dirnhofer, Nora Gisin, Karen Dybkaer, Attilio Orazi, Govind Bhagat, Kristy L Richards,[...]. Mod Pathol 2014
94
100


Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial.
Andrew Davies, Thomas E Cummin, Sharon Barrans, Tom Maishman, Christoph Mamot, Urban Novak, Josh Caddy, Louise Stanton, Shamim Kazmi-Stokes, Andrew McMillan,[...]. Lancet Oncol 2019
112
100

Stromal gene signatures in large-B-cell lymphomas.
G Lenz, G Wright, S S Dave, W Xiao, J Powell, H Zhao, W Xu, B Tan, N Goldschmidt, J Iqbal,[...]. N Engl J Med 2008
100

LAG3: a novel immune checkpoint expressed by multiple lymphocyte subsets in diffuse large B-cell lymphoma.
Colm Keane, Soi C Law, Clare Gould, Simone Birch, Muhammed B Sabdia, Lilia Merida de Long, Gayathri Thillaiyampalam, Emad Abro, Joshua W Tobin, Xiaohong Tan,[...]. Blood Adv 2020
41
100

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.
A A Alizadeh, M B Eisen, R E Davis, C Ma, I S Lossos, A Rosenwald, J C Boldrick, H Sabet, T Tran, X Yu,[...]. Nature 2000
100

ROBUST: Lenalidomide-R-CHOP versus placebo-R-CHOP in previously untreated ABC-type diffuse large B-cell lymphoma.
Grzegorz S Nowakowski, Annalisa Chiappella, Thomas E Witzig, Michele Spina, Randy D Gascoyne, Lei Zhang, Jocelyne Flament, Jacqueline Repici, Umberto Vitolo. Future Oncol 2016
66
100

Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma.
Michael R Green, Andrew J Gentles, Ramesh V Nair, Jonathan M Irish, Shingo Kihira, Chih Long Liu, Itai Kela, Erik S Hopmans, June H Myklebust, Hanlee Ji,[...]. Blood 2013
209
100

Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.
Daisuke Ennishi, Aixiang Jiang, Merrill Boyle, Brett Collinge, Bruno M Grande, Susana Ben-Neriah, Christopher Rushton, Jeffrey Tang, Nicole Thomas, Graham W Slack,[...]. J Clin Oncol 2019
153
100

The combined expression of the stromal markers fibronectin and SPARC improves the prediction of survival in diffuse large B-cell lymphoma.
Simone Brandt, Chiara Montagna, Antoin Georgis, Peter J Schüffler, Marco M Bühler, Burkhardt Seifert, Thore Thiesler, Alessandra Curioni-Fontecedro, Ivan Hegyi, Silvia Dehler,[...]. Exp Hematol Oncol 2013
12
100

Profiling Cell Type Abundance and Expression in Bulk Tissues with CIBERSORTx.
Chloé B Steen, Chih Long Liu, Ash A Alizadeh, Aaron M Newman. Methods Mol Biol 2020
86
100

An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation.
George P Souroullas, William R Jeck, Joel S Parker, Jeremy M Simon, Jie-Yu Liu, Joshiawa Paulk, Jessie Xiong, Kelly S Clark, Yuri Fedoriw, Jun Qi,[...]. Nat Med 2016
126
100

The Tumor Microenvironment of DLBCL in the Computational Era.
Giuseppina Opinto, Maria Carmela Vegliante, Antonio Negri, Tetiana Skrypets, Giacomo Loseto, Stefano Aldo Pileri, Attilio Guarini, Sabino Ciavarella. Front Oncol 2020
15
100

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.
Roland Schmitz, George W Wright, Da Wei Huang, Calvin A Johnson, James D Phelan, James Q Wang, Sandrine Roulland, Monica Kasbekar, Ryan M Young, Arthur L Shaffer,[...]. N Engl J Med 2018
881
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.